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Stone formation in genetic hypercalciuric rats. Our genetic hypercalci-
uric (GH) rats have been selected and inbred for 29 generations to
maximize urine calcium (U,) excretion compared to identical gender
controls (Ct!). To determine the effect of the increased Ua on urinary
supersaturation and stone formation, we pair fed 15 GH and 15 Ctl rats a
standard 1.2% calcium diet for 18 weeks, measured urine supersaturation
every two weeks, and examined the urinary tract of 1/3 of the rats for the
presence of stones every six weeks. Any stones formed were studied by
SEM, X-ray and electron diffraction and X-ray microanalysis. Over the
entire study was increased in the GH compared to Ctl, resulting in
greater supersaturation with respect to calcium hydrogen phosphate(CaHPO4) at all times and calcium oxalate (CaOx) at most times. There
was a progressive increase in the incidence of stone formation in GH rats
with one of five rats having stones at six weeks, three of five with stones at
12 weeks and five of five with stones at 18 weeks. There were no stones
formed in Ctl rats. SEM reveals discrete stones and not nephrocalcinosis.
X-ray and electron diffraction and X-ray microanalysis reveal the stones to
be poorly crystalline apatite which is a solid phase of calcium and
phosphate. Compared to Ctl, in the GH rats the saturation ratio for
CaHPO4 increased proportionally more than that for CaOx, perhaps
explaining why the rats formed apatite and not oxalate stones. This is the
first description of an animal model of spontaneous nephrolithiasis.
Idiopathic hypercalciuria (IH) is common in patients with
nephrolithiasis and raises urinary supersaturation with respect to
calcium oxalate (CaOx), the most common solid phase found in
renal stones, as well as brushite (CaHPO4) [11. Evidence suggests
a genetic origin for IH [2], whose pathogenesis involves a complex
mixture of increased intestinal absorption of calcium, abnormal
vitamin D metabolism and decreased renal tubule calcium reab-
sorption [3, 4].
Through 29 generations of successive inbreeding of the most
hypercalciuric progeny we have established a colony of rats, each
of which excrete abnormally large amounts of urinary calcium
[5—81. We have shown that the increase in urine calcium excretion
leads to an increase in urinary supersaturation with respect to
brushite and calcium oxalate [5]. Analogous to patients with
idiopathic hypercalciuria, we have shown that a principal mecha-
nism of excessive calcium excretion in these rats appears to be a
primary increase in intestinal calcium absorption [6, 8], which is
not mediated by elevated levels of serum 1,25(OH)2D3, hut
appears related to an increased number of intestinal 1,25(OH)2D3
receptors [7]. Apart from the increased calcium excretion the rats
display no consistent abnormalities of blood or urine chemistry
thus far detected [5—81.
The purpose of the current study was to determine the effect of
the isolated increase of urinary calcium excretion on stone
formation. We tested the hypothesis that the increase in urine
calcium excretion alone would result not only in an increase in
urine supersaturation with respect to the solid phases of calculi
but lead to stone formation. This hypothesis is in contrast to an
alternative hypothesis concerning stone formation, that assumes a
complex and multifactorial basis for stones. We found that over
the entire study urine calcium excretion was increased in the
genetic hypercalciuric rats compared to controls, resulting in a
greater supersaturation with respect to both CaHPO4 and CaOx,
and that CaHPO4 supersaturation increased more that CaOx
supersaturation. There was a progressive increase in the incidence
of stone formation in the GH rats with no stones formed in the
controls. All stones studied were composed exclusively of calcium
hydrogen phosphate.
Methods
Establishment of hypercalciuric rats
Initially 20 male and 20 female adult Sprague-Dawley rats
(Charles River Laboratories, Kingston, NY, USA) were screened
for hypercalciuria. The rats were placed in individual metabolic
cages and allowed five days to adjust to the cage and diet. During
this time, the animals were fed 13 g/day of a diet containing 1.2%
calcium, 0.65% phosphorus, 0.24% magnesium, 0.40% sodium
and 0.43% potassium and 2.2 IU vitamin D3/g of food. Deionized
distilled water was provided ad libitum. Two successive 24-hour
urine collections in 0.25 ml 12 N HC1 were then obtained on days
6 and 7 to measure the urine calcium excretion. The three male
and three female rats with the greatest calcium excretion were
used to breed the next generation. A similar protocol was used to
select the two to three most hypercalciuric males and three to four
most hypercalciuric females for inbreeding of subsequent gener-
ations [5—8].
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Twenty ninth generation female hypercalciuric rats were kept in
the metabolic cages and continued on the same diet for a total of
18 weeks. Control rats were housed and fed identically. Rats were
pair fed; the hypercalciuric rats were offered an unlimited diet and
the paired control rat was given the same amount of food on the
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Fig. 1. Urine calcium (A), phosphorus (B) and oxalate (C) excretion in the
control (Ct!, A) and genetic hypercalciuric (GH, A) rats. Rats were pair fed
a 1.2% calcium, 0.65% phosphorus diet; the GH rats were offered
unlimited diet and the paired Ctl rat was given the same amount of food
on the next day. There were 15 rats in each group in the first six weeks, 10
in each group in the second six weeks and 5 in each group in the last six
weeks of the study. Mean urine calcium excretion in the GH rats was
greater than Ctl during each of the three six week intervals. There was no
difference in phosphate or oxalate excretion between the Ctl and GH rats
during any of the intervals.
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Fig. 2. Urine pH (A) and volume (B) and rat weight (C) in the control (Ctl,
A) and genetic hypercalciuric (GH, A) rats. Rats were pair fed a 1.2%
calcium, 0.65% phosphorus diet; the GH rats were offered unlimited diet
and the paired Ctl rat was given the same amount of food on the next day.
There were 15 rats in each group in the first six weeks, 10 in each group
in the second six weeks and 5 in each group in the last six weeks of the
study. Mean urine pH was decreased in the GH compared to the Ctl rats
over the second, but not the first or third six-week interval studied. Mean
urine volume was increased in the GH compared to the Ctl rats over all
three six-week intervals. Mean rat weight was increased in the Ctl
compared to the GH rats during weeks 2 through 10.
Chemical determinations
Calcium was determined by reaction with arsenazo III and then
determined photometrically at 650 nm [9]. Creatinine was deter-
mined by a modification of the Jaffe method by formation of a
creatinine-picrate complex at 520 nm [101. Inorganic phosphorus
by reaction with ammonium molybdate to form a colored
phosphomolybdate complex [11]. Uric acid was measured after
oxidation by uricase to produce allantoin and hydrogen peroxide.
The hydrogen peroxide reacts with 4-amino-antipyrine and 3,5-
dichloro-2-hydroxybenzene sulfonate in a reaction catalyzed by
peroxidase to produce a quinoneimine which is monitored at 520
nm [12]. Magnesium was determined by combination with calm-
agite and monitored at 520 nm [13]. Ammonia was determined by
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next day. Over the course of the study the mean daily consump-
tion of food varied between 15.0 1.4 and 21.3 0.4 g per day,
with an overall mean consumption of 19.4 0.2 g. The control
rats were the same gender, the same Strain (Sprague-Dawley)
obtained from the same supplier, and were studied concurrently
at the same age and weight as the inbred hypercalciuric rats. Every
two weeks urine was collected in thymol and frozen at —70°C for
subsequent biochemical determinations. Every six weeks one third
of the hypercalciuric and control rats were sacrificed and their
entire urinary tract was examined, by direct vision, for stones. The
kidneys, ureters and bladder were dissected in block and mounted
on radiographic film. Any stone found was analyzed for crystal
type and composition (see below). Any rat that ate less than 10 g
of food or drank less than 15 ml of water on any day of the study
was excluded from the entire study. coupled enzyme system using glutamate dehydrogenase and
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Fig. 3. Relative saturation ratio of brushite (A, CaHPO4) and calcium
oxalate (B, CaOx) in the control (Ctl, A) and the genetic hypercalciuric (GH,
A) rats. Rats were pair fed a 1.2% calcium, 0.65% phosphorus diet; the
GH rats were offered unlimited diet and the paired Ctl rat was given the
same amount of food on the next day. There were 15 rats in each group in
the first six weeks, 10 in each group in the second six weeks and 5 in each
group in the last six weeks of the study. The relative supersaturation for
CaHPO4 is calculated as the ratio of the free-ion activity product of
calcium and phosphate in the individual urine to the solubility of CaHPO4.
The relative supersaturation for CaOx is calculated as the ratio of the
free-ion activity product of calcium and oxalate in the individual urine to
the solubility of CaOx. There was greater mean brushite supersaturation
during each of the three six-week intervals and greater calcium oxalate
excretion during the first and third, but not the second, three-week
interval.
NADPH and monitored at 340 nm [141. Sodium was determined
by a selective electrode [15] and potassium using a valinomycine
membrane attached to a potassium electrode [161. Chloride was
measured by colorimetry using a silver/silver chloride electrode
[17]. Oxalic acid was measured utilizing oxalate oxidase which
oxidizes oxalate to hydrogen peroxide and carbon dioxide. The
hydrogen peroxide then reacts with 3-methly-2-benzothiazolinone
hydrozone and 3-(dimethyl)benzoic acid to form an indamine dye
which is monitored at 590 nm [18]. Citric acid was determined
using citrate lyase that catalyzes the conversion citrate to oxalo-
acetic acid, which is then converted to malic acid, in the presence
of malate dehydrogenase. The malic acid oxidizes NADH to
NAD which is monitored at 340 nm [191. pH was measured by an
ion selective electrode.
Urinaiy supersaturation
The calcium oxalate ion activity product was calculated using
the computer program EQUIL developed by B. Finlayson and
associates [20, 211. The computer program calculates free ion
concentrations using the concentrations of measured ligands and
known stability constants. Ion activity coefficients are calculated
from ionic strength using the Davies modification of the Debye-
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Fig. 4. Relative saturation ratio of brushite (A, CaHPO4) and calcium
oxalate (B, Ca Ox) as a function of urinaiy calcium excretion in the control
(Cd, A) and the genetic hypercalciuric (GH, A) rats. Rats were pair fed a
1.2% calcium, 0.65% phosphorus diet; the GH rats were offered unlimited
diet and the paired Ctl rat was given the same amount of food on the next
day. There were 15 rats in each group in the first six weeks, 10 in each
group in the second six weeks and 5 in each group in the last six weeks of
the study. The relative supersaturation for CaHPO4 is calculated as the
ratio of the free-ion activity product of calcium and phosphate in the
individual urine to the solubility of CaHPO4. The relative supersaturation
for CaOx is calculated as the ratio of the free-ion activity product of
calcium and oxalate in the individual urine to the solubility of CaOx. There
is a direct correlation between brushite supersaturation and urinary
calcium excretion and between calcium oxalate supersaturation and
urinary calcium excretion.
Huckel solution to the Poisson-Boltzman equation. The program
simultaneously solves for all known binding interactions among
the measured substances. Oxalate, phosphorus and calcium ion
activities were used to calculate the free-ion activity products. The
free ions in solution are considered to be in an equilibrium with
the dissolved calcium oxalate governed by a stability constant (K)
of 2.746 X iO M1 and with the dissolved brushite governed by a
K of 0.685 X iO M1. The value of calcium oxalate in a solution
at equilibrium with a solid phase of calcium oxalate, the solubility
of calcium oxalate, is 6.16 X 10—6 M per liter. The value of the
brushite in a solution at equilibrium with a solid phase of brushite,
the solubility of brushite, is 3.98 1 X iO M per liter. The relative
supersaturation for calcium oxalate is calculated as the ratio of the
free-ion activity product of calcium and oxalate in the individual
urine to the solubility of calcium oxalate. The relative supersatu-
ration for brushite is calculated as the ratio of the free-ion activity
product of calcium and phosphate in the individual urine to the
solubility of calcium phosphate. Ratios of I connote a sample at
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Fig. 5. Change in the relative saturation ratio of calcium oxalate (CaOx)
compared to the change in the relative saturation of brushite (CaHPO4) for
the paired genetic hypercalciuric compared to the control rats. Rats were pair
fed a 1.2% calcium, 0.65% phosphorus diet; the OH rats were offered
unlimited diet and the paired control rat was given the same amount of
food on the next day. There were 15 rats in each group in the first six
weeks, 10 in each group in the second six weeks and 5 in each group in the
last six weeks of the study. The relative supersaturation for CaHPO4 is
calculated as the ratio of the free-ion activity product of calcium and
phosphate in the individual urine to the solubility of CaHPO4. The relative
supersaturation for CaOx is calculated as the ratio of the free-ion activity
product of calcium and oxalate in the individual urine to the solubility of
CaOx. Values are the differences of the means (± SD) of the GH rats
minus the Ctl over the GH rats times 100. Absence of error bars indicates
that the SD was less than the height and/or width of the symbol. There was
greater increase in supersaturation with respect to brushitc than to
calcium oxalate in eight of the nine biweekly urine collections from the
GH compared to Ctl rats.
equilibrium, above 1 supersaturation, and below 1 undersatura-
tion.
The ability of this computer program to accurately predict the
saturation of urine or other solution with respect to the solid
phase is excellent [5, 6, 20, 22—24]. With a series of 20 artificial
solutions the equilibrium calcium concentration and the extent of
calcium precipitation were predicted with average errors of 5
9% and 5 8% (mean SD), respectively [20]. We have used this
computer program previously and found excellent correspon-
dence between calculated and experimentally measured satura-
tions in urine and blood [5, 6, 24] and in bone culture medium [22,
23].
Transmission electron microscopy, X-ray microanalysis and
electron diffraction
Small pieces of the stones were placed in Beem capsules and
embedded in Spurr epoxy resin without any chemical fixation or
dehydration. The blocks were cut on a Sorval MT6000 microtome
with a diamond knife. Two hundred nm sections were placed on
carbon-coated formvar grids for microanalysis and selected area
electron diffraction. Microscopy was carried out on a Phillips
Ctl GH
Fig. 6. Number of rats who formed stones in the control (, Ctl) and genetic
hypercalciuric • GH) rats. There was a progressive increase in the
number of Stones formed with time in the OH rats, by 18 weeks all rats
formed stones. There was no stone formation in the control rats.
EM430 equipped with an Oxford Instruments AN10000 micro-
analysis system.
Scanning electron microscopy
Pieces of the stones were attached to aluminum stubs with
two-sided tape, sputter coated with gold and viewed in a JEOL
820 at 5 Ky.
X-ray diffraction
The stones were finely powdered and put in a glass capillary to
be examined in an X-ray diffraction Debye-Sherrer powder cam-
era using Cu Ku radiation (1.5418 A) with an exposure time of
four hours at 40 KV and 25 ma. The recorded diffraction patterns
were compared to standard hydroxyapatite pattern.
Results
Urine excretion and saturation
Urine calcium excretion was increased in the GH compared to
Ctl rats over the first, second and third six-week intervals studied
(Fig. 1). There was no difference in urine phosphorus, oxalate,
sodium, or magnesium (data not shown) at any time. Urine pH
was decreased in the OH compared to the Ctl rats over the
second, but not the first or third six-week interval studied (Fig. 2).
Mean urine volume was increased in the GH compared to the Ct!
rats over all three six-week intervals. Mean rat weight was
increased in the Ct! compared to the OH rats during weeks 2
through 10.
The increase in urine calcium excretion, even with an increase
in urine volume, in the GH rats resulted in a significant increase
in the saturation ratio for CaHPO4 during all three six-week
intervals and for CaOx only on the first and third intervals (Fig. 3).
There was a direct correlation between urine calcium excretion
and the saturation ratio for CaHPO4 and for CaOx (Fig. 4).
There was a greater increase in saturation with respect to
CaHPO4, compared to CaOx, in the GH compared to the Ctl rats
in eight of the nine biweekly urine collections (Fig. 5).
Stone formation
At the end of six weeks, one of the five OH rats and none of the
five Cii rats formed radiographically visible stones (Fig. 6). At the
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Fig. 7. Radiographs of stone formation in two representative genetic hyper-
calciuric rats demonstrating nephrolithiasis in both sets of kidneys and
ureteral obstruction in the right ureter of the kidneys on the left. Radiographs
were obtained by placing the dissected kidneys, ureters and bladder on
radiographic film, no contrast material was utilized.
end of 12 weeks, three of the five GH rats and none of the five Ctl
rats formed radiographically visible stones, and at the end of 18
weeks five of the five GH rats and none of the five Ctl rats formed
radiographically visible stones, The stones ranged from solitary
stones, to multiple stones to ureteral stones (Fig. 7, representative
radiographs). There were no stones visible in the kidneys from Ctl
rats.
Stone identification
Scanning electron microscopy reveals discrete calculi and not
nephrocalcinosis (Fig. 8). X-ray diffraction patters of individual
calculi from GH rats each demonstrated the typical diffraction
pattern of poorly crystalline hydroxyapatite (Fig. 9).
We show an electron micrograph of a single calculi, typical of
all the stones found, from an GH rat (magnification x24,300)
which had an electron diffraction pattern consistent with hydroxy-
apatite apatite; X-ray microanalysis of a selected area from the
same stone demonstrated the presence of calcium and phospho-
rus (Fig. 10).
Discussion
Inbred hypercalciuric rats excrete excessive amounts of urine
calcium resulting in urinary supersaturation with respect to the
solid phases of calcium oxalate (CaOx) and brushite (CaHPO4).
In this study we found that the urinary supersaturation with
respect to CaOx and CaHPO4 both increased, but the supersatu-
ration with respect to CaHPO4 increased more than the super-
saturation with respect to CaOx. Stone formation occurred in
these rats and was universal by the I 8th week of the study. Analysis
of the stones revealed poorly crystalline apatite which is a solid
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Fig. 8. A magnification series of scanning electron micrograph from a
genetic hypercalciuric rat stone showing the ultrastructure and organization of
the ciystals: A. magnification ><140; B, magnification of X1500; C, magni-
fication of x5000.
phase of calcium and phosphate. There was no stone formation in
the control rats. These data support the hypotheses that increased
urinary supersaturation alone can lead to stone formation, in that
hypercalciuria was the solitary abnormality and that supersatura-
tion is the critical determinant of stone formation because the
solid phase of the stones reflected the predominant urine super-
saturation. This study provides the first description of an animal
model for spontaneous nephrolithiasis while the animal was
consuming a normal diet.
That moderate urinary supersaturation leads to stone forma-
tion is presumed but has never been rigorously tested [1]. Clearly
at the extreme of an unstable solution there will be spontaneous
crystallization; however, in humans urine almost never achieves
such a marked increase in supersaturation. Furthermore, IH
occurs in approximately 5% of the population, of whom many do
not form stones [1]. In fact, it is possibly surprising that, given
urine supersaturations similar to those present in humans [1], all
of our rats displayed stone formation.
During one of the three six-week time intervals there was an
increase in urine pH in the Ctl compared to the GH rats. That the
urine pH was not higher in the GH compared to the Ctl rats
indicates that the stone formation was not simply due to an
increase in urine pH which would promote formation of calcium
phosphate, brushite or apatite stones. An increase in urine pH is
responsible, in part, for the nephrocalcinosis and nephrolithiasis
observed in patients with distal renal tubular acidosis [25, 261.
Urine volume was consistently increased in the GH compared to
the Ct! rats. Further studies will be necessary to determine if the
hypercalciuria and stone formation interfere with the urinary
concentrating ability in these rats.
In humans the majority of stones are composed of a mixture of
calcium oxalate and calcium phosphate (brushite or apatite) [1].
In the current study, the relative supersaturation for brushite
increased proportionally more than that for calcium oxalate (Fig.
5), and the rats formed only stones composed of a poorly
crystalline apatite and not of calcium oxalate or a mixture of both
(Figs. 8 and 9). We certainly cannot conclude that the relative
preponderance of CaHPO4 supersaturation alone is responsible
for the universal formation of apatite stones. There are a number
of urinary inhibitors of stone formation [27—3 1]. The data in this
study do not allow us to determine the role, if any, of these
inhibitors in influencing the type of calculi formed. Perhaps urine
contains more effective inhibitors of calcium oxalate than for
calcium hydrogen phosphate, allowing greater supersaturations to
be tolerated without the formation of calculi.
In this study we utilized female rats because we had previously
shown that when compared to males the females exhibited greater
calcium excretion [32], and we speculated that they might be more
prone to form renal stones. Further studies will be necessary to
determine if male rats would form calculi, and if they do, what
type of stones would be formed over a particular time period.
There are many other models of stone formation in animals,
including rats, but in no case is the stone formation spontaneous
as in our animals [3—1 Recently investigators have induced
stone formation by increasing urinary oxalate excretion through
administration of oral glycollate, a metabolic precursor of oxalate
[35—37], oral ammonium oxalate [41], oral or injected ethylene
glycol [38, 39, 43, 44], or simply the administration of oral or
injected sodium oxalate [34, 40]. Some models have increased
calcium excretion by the injections of vitamin D3 [44] or provision
of ammonium chloride [381, or have increased magnesium excre-
tion by adding magnesium to the diet [42]. Renal tubule injury
induced by gentamicin has also been utilized to promote stone
formation [41, 43]. Additionally, cholesterol has been shown to
promote stone formation in rats [33]. However, in each of these
cases the stone formation is induced by external manipulations,
and thus it is unclear how representative these models are of
naturally-occurring stone formation due to idiopathic hypercalci-
uria. The model described here appears to be particularly suited
to test interventions aimed at preventing stone formation. In this
rat model we can control diet and environment and administer
therapy more precisely than is possible in humans.
Each pair of rats chosen for mating in each of the preceding
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Fig. 9. X-ray diffraction patterns of genetic hypercalciuric rat stones showing the typical diffraction pattern of poorly ciystalline apatite found in biological
mineralization.
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Fig. 10. A. Electron micrograph of a rat stone (magnification ><24,300). B. Electron diffraction pattern of crystals from the above micrograph showing
an apatite diffraction pattern. C. X-ray microanalysis of a selected area from the above micrograph showing that only calcium and phosphorus are
present in the calcified area. The peak at higher energy comes from the calcium grid.
generations was selected on the basis of maximal urine calcium 2). In this study the magnitude of the urine calcium excretion in
excretion. Excretion of all other measured ions was not consis- both the control and hypercalciuric rats was greater than we have
tently altered by this selection process; urinary calcium was the reported previously [5—8, 321. The increase in urine calcium
only measured ion that had an augmented excretion (Figs. I and excretion in both the hypercalciuric and control rats appears due
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to two reasons. In previous studies we fed both the control and
hypercalciuric rats exactly 13 g of food per day; they were not pair
fed [5—8]. In this study we fed the hypercalciuric rats an unlimited
amount of food and then fed the paired control rat the amount of
food that the hypercalciuric rat consumed (Methods). This re-
sulted in the rats consuming approximately 19 g of food per day
and would therefore provide the rats with approximately 46%
more dietary calcium. There is clear evidence that increasing
dietary calcium will increase urinary calcium in both rats [6] and
humans [451. Additionally, in most previous studies the rats were
consuming a 0.6% calcium diet [5—8, 32] while in this study they
consumed a 1.2% calcium diet; again, the increase in dietary
calcium would result in an increase in urinary calcium [6].
The principal mechanism of hypercalciuria in these inbred
hypercalciuric rats appears to be an increase in intestinal calcium
absorption [8], although there appears to be a lesser, but signifi-
cant, component of enhanced bone demineralization either as a
primary process or mediated through enhanced renal calcium
excretion [6]. Therefore, it is not surprising that in this study urine
calcium excretion was greater than in previous studies due to the
increase in dietary calcium both as a function of the amount of
diet fed to the rats and the percentage of calcium in the diet.
This study provides the first description of spontaneous neph-
rolithiasis in an inbred strain of rats. The stones form from urine
that is supersaturated with respect to both calcium oxalate and
calcium hydrogen phosphate due to a marked increase in urine
calcium excretion. Each of the stones analyzed is composed of a
poorly crystalline apatite.
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